Health & Environmental Research Online (HERO)


Print Feedback Export to File
6324940 
Journal Article 
Abstract 
Clinical usefulness of the ultrasound contrast agent perflubutane in the diagnosis of prostatic cancer: A prospective clinical trial 
Akatsuka, J; Kimura, G; Suzumura, K; Nomura, S; Minowa, T; Iigaya, S; Osawa, S; Kondo, Y 
2012 
1 
Urology
ISSN: 0090-4295
EISSN: 1527-9995 
80 
3 
S12 
English 
WOS:000209846800025 
PFAS
• Additional PFAS (formerly XAgency)
• PFAS Universe
     Data Source
          Web of Science
          Screened Studies
               Excluded
                    Exclude (TIAB)
     Perfluorobutane